Industry 4.0 and Bioprint in Regenerative Medicine
Abstract
Due to the current scenario of aging in Brazilian population and the consequent increase inthe prevalence of chronic diseases, biofabrication emerges as an alternative to treatment of tissuelosses, introducing novel interventionist protocols through translational research practice. Thetissue and organ bioprinting as a branch of biofabrication is a diversification of biomedicalapplication from 3D printing for the replacement or regeneration of tissues and organs.The objective of this workshop is to show the potential of using stem cells in regenerativemedicine and biofabrication with a focus on bioprinting. Currently Brazil is experiencing aregulatory movement that involves the implementation and registration of advanced cellulartherapy products, as explained in the recently published RDC 214/2018 of ANVISA. One of ourmain objectives is to foster the translation through the interaction of professionals and/or researchand innovation institutions. This event will support the US Naval or Marine Corp Science &Technology Plan in offering reliable autologous ex vivo tissue engineered by combiningbioprinting approaches and knowledge in stem cells biology.In addition to this, we live in our country today an unprecedented enthusiasm forentrepreneurship and innovation. Startups, accelerators, venture capital, angel investment,fintechs, healthtechs, hubs, are part of national daily life. Among the potential speakers we willhave international and national researchers from Startups, Universities and Research Centersactive in the field of regenerative medicine, tissue engineering and bioprinting.Our workshop will also have the presence of speakers in innovation and entrepreneurshipfields, in addition to the presence of an agent of the Management of Blood, Tissue, Organ andCells, from ANVISA. The target audience of the proposed workshop will be postgraduatestudents, health professionals, entrepreneurs in the area of Biotechnology, researchers andtechnicians, covering the basic, applied and clinical research. We consider it crucial to stimulatethe translation of Brazilian research focusing on the socioeconomic development of the state ofRio de Janeiro.One of the expected short-term impacts is the stimulation of research and development in thearea of Regenerative Medicine, through the strengthening and creation of new networks ofnational and international collaborations, culminating in the generation of knowledge and newtechnologies.
Document Details
- Document Type
- DoD Grant Award
- Publication Date
- Mar 11, 2020
- Source ID
- N629092012011
Entities
People
- Leandra S Baptista
Organizations
- Office of Naval Research
- United States Navy